- Home
- EDAP vs ATRA Comparison
EDAP vs ATRA Comparison
Compare EDAP & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDAP
- ATRA
- Stock Information
- Founded
- EDAP 1979
- ATRA 2012
- Country
- EDAP France
- ATRA United States
- Employees
- EDAP N/A
- ATRA N/A
- Industry
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EDAP Health Care
- ATRA Health Care
- Exchange
- EDAP Nasdaq
- ATRA Nasdaq
- Market Cap
- EDAP 53.8M
- ATRA 51.1M
- IPO Year
- EDAP 1997
- ATRA 2014
- Fundamental
- Price
- EDAP $1.54
- ATRA $10.15
- Analyst Decision
- EDAP Buy
- ATRA Strong Buy
- Analyst Count
- EDAP 3
- ATRA 4
- Target Price
- EDAP $8.50
- ATRA $20.00
- AVG Volume (30 Days)
- EDAP 44.7K
- ATRA 36.9K
- Earning Date
- EDAP 08-27-2025
- ATRA 08-11-2025
- Dividend Yield
- EDAP N/A
- ATRA N/A
- EPS Growth
- EDAP N/A
- ATRA N/A
- EPS
- EDAP N/A
- ATRA N/A
- Revenue
- EDAP $67,840,467.00
- ATRA $199,732,000.00
- Revenue This Year
- EDAP N/A
- ATRA N/A
- Revenue Next Year
- EDAP N/A
- ATRA N/A
- P/E Ratio
- EDAP N/A
- ATRA N/A
- Revenue Growth
- EDAP 3.69
- ATRA 475.53
- 52 Week Low
- EDAP $1.26
- ATRA $5.01
- 52 Week High
- EDAP $5.17
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- EDAP 41.95
- ATRA 70.65
- Support Level
- EDAP $1.51
- ATRA $8.53
- Resistance Level
- EDAP $1.59
- ATRA $9.62
- Average True Range (ATR)
- EDAP 0.09
- ATRA 0.53
- MACD
- EDAP 0.00
- ATRA 0.10
- Stochastic Oscillator
- EDAP 32.14
- ATRA 100.00
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).